David R Hockmuth MD FACS
Adult Cardiac Surgery, Aortic Surgery, Minimally Invasive Cardiac Surgery, Pediatric Cardiac Surgery
Director of Pediatric and Adult Congenital Cardiac Surgery Surgical Director of ECMO MercyOne Childrens Hospital MercyOne Medical Center Des Moines
Join to View Full Profile
2790 Clay Edwards Dr Ste 520bNorth Kansas City, MO 64116
Phone+1 816-691-5198
Fax+1 816-346-7095
Dr. Hockmuth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Hockmuth is a thoracic surgeon in West Des Moines, IA and is affiliated with Mercy Medical Center-Des Moines. He received his medical degree from University of Iowa Carver College of Medicine and has been in practice 34 years. He specializes in adult cardiac surgery, aortic surgery, minimally invasive cardiac surgery, and pediatric cardiac surgery and is experienced in extracorporeal membrane oxygenation, adult general thoracic surgery, aortic surgery, minimally invasive cardiac surgery, and minimally invasive thoracic surgery.
Education & Training
West Virginia University School of MedicineFellowship, Thoracic Surgery - Independent, 1988 - 1990
Berkshire Medical CenterResidency, Surgery, 1983 - 1988
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1983
Certifications & Licensure
MO State Medical License 2024 - 2026
IA State Medical License 1992 - 2025
LA State Medical License 1990 - 1996
WV State Medical License 1988 - 1991
American Board of Thoracic Surgery Thoracic and Cardiac Surgery- American Board of Thoracic Surgery Congenital Cardiac Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
Publications & Presentations
PubMed
- 7 citationsFunctional Status After Transcatheter and Surgical Aortic Valve Replacement: 2-Year Analysis From the SURTAVI Trial.Mark K Tuttle, Bob Kiaii, Nicolas M Van Mieghem, Roger J Laham, G Michael Deeb
JACC. Cardiovascular Interventions. 2022-04-11 - The Impact of Transfusions on Mortality After Transcatheter or Surgical Aortic Valve ReplacementMubashir Mumtaz, Moritz C. Wyler von Ballmoos, G. Michael Deeb, Jeffrey J. Popma, Nicolas M. Van Mieghem
The Annals of Thoracic Surgery. 2021-09-01 - 11 citationsComparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass ...Michael J. Reardon, Robin H. Heijmen, Nicolas M. Van Mieghem, Mathew R. Williams, Steven J. Yakubov
JAMA Cardiology. 2019-08-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
